Recommendations for the Use of Prolonged-Release Fampridine in Patients with Multiple Sclerosis (MS)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recommendations for the Use of Prolonged-Release Fampridine in Patients with Multiple Sclerosis (MS)

Published:2013-04-22 Issue:5 Volume:19 Page:302-306
ISSN:1755-5930
Container-title:CNS Neuroscience & Therapeutics
language:en
Short-container-title:CNS Neurosci Ther

Author:

Preiningerova Jana Lizrova¹,Baumhackl Ulf²,Csepany Tunde³,Czaplinski Adam⁴,Deisenhammer Florian⁵,Derfuss Tobias⁶,Fabjan Tanja H.⁷,Fazekas Franz⁸,Fuchs Siegrid⁸,Havrdova Eva¹,Ledinek Alenka Horvath⁹,Illes Zsolt¹⁰,Jazbec Sasa Sega⁹,Klimova Eleonora¹¹,Komoly Samuel¹⁰,Kurca Egon¹²,Linnebank Michael¹³,Lisy Lubomir¹⁴,Mares Jan¹⁵,Prochazkova Lubica¹⁶,Csilla Rozsa¹⁷,Szilasiova Jarmila¹¹,Stourac Pavel¹⁸,Talab Radomir¹⁹,Turcani Peter²⁰,Vachova Marta²¹,Vecsei Laszlo²²,Vodusek David²³,Zapletalova Olga²⁴,Berger Thomas⁵

Affiliation:

1. Department of Neurology and Center for Clinical Neuroscience; Charles University; General Hospital; Prague Czech Republic

2. Neurological Practice; Vienna Austria

3. Department of Neurology; University of Debrecen; Medical and Health Science Center; Debrecen Hungary

4. Department of Neurology; University of Basel; Basel Switzerland

5. Department of Neurology; Innsbruck Medical University; Innsbruck Austria

6. Department of Neurology; University Hospital Basel; Basel Switzerland

7. Department of Neurology; School of Medicine; Maribor Slovenia

8. Department of Neurology; Medical University of Graz; Graz Austria

9. Department of Neurology; University of Ljubljana; Ljubljana Slovenia

10. Department of Neurology; University of Pécs; Pécs Hungary

11. Department of Neurology; School of Medicine; Kosice Slovak Republic

12. Department of Neurology; School of Medicine; Martin Slovak Republic

13. Department of Neurology; University Hospital Zurich; Zurich Switzerland

14. Department of Neurology; School of Medicine; Bratislava Slovak Republic

15. Department of Neurology; University of Palacky; Olomouc Czech Republic

16. Department of Neurology; University Hospital; Bratislava Slovak Republic

17. Department of Neurology; Jahn Ferenc Hospital; Budapest Hungary

18. Department of Neurology; University Hospital; Brno Czech Republic

19. Department of Neurology; University Hospital; Hradec Kralove Czech Republic

20. Department of Neurology; Comenius University; Bratislava Slovak Republic

21. Department of Neurology; Hospital of Teplice; Teplice Czech Republic

22. Department of Neurology; University of Szeged; Szeged Hungary

23. Division of Neurology; University of Ljubljana; Ljubljana Slovenia

24. Department of Neurology; University Hospital Ostrava; Ostrava Czech Republic

Publisher

Wiley

Subject

Pharmacology (medical),Physiology (medical),Psychiatry and Mental health,Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cns.12101/fullpdf

Reference24 articles.

1. Employment in multiple sclerosis. Exiting and re-entering the work force;Julian;J Neurol,2008

2. Patient perception of bodily function in multiple sclerosis: Gait and visual function are the most valuable;Heesen;Mult Scler,2008

3. What drives quality of life in multiple sclerosis?;Hemmett;QJM,2004

4. Walking capacities in multiple sclerosis measured by global positioning system odometer;Creange;Mult Scler,2007

5. 4 Aminopyridine improves clinical signs in multiple sclerosis;Stefoski;Ann Neurol,1987

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conductive conduit based on electrospun poly (l-lactide-co-D, l-lactide) nanofibers containing 4-aminopyridine-loaded molecularly imprinted poly (methacrylic acid) nanoparticles used for peripheral nerve regeneration;International Journal of Biological Macromolecules;2021-11

2. Efficacy and safety of Kinezia (fampridine) in the complex therapy of multiple sclerosis;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2020

3. Evaluating dalfampridine for the treatment of relapsing-remitting multiple sclerosis: does it add to the treatment armamentarium?;Expert Opinion on Pharmacotherapy;2019-06-25

4. Experience with fampridine in clinical practice: analysis of a possible marker of clinical response;International Journal of Neuroscience;2017-03-30

5. The Effects of Dalfampridine on Hereditary Spastic Paraparesis;European Neurology;2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3